Overnight Health Care – Brought to you by the National Council for Mental Wellness – FDA panel approves Johnson & Johnson vaccine booster injections


Welcome to Friday night health care, where we follow the latest policy developments and news affecting your health. Subscribe here: thehill.com/newsletter-inscription.

We hope you are in a good mood this Friday. And if not, you can celebrate National Grunt Day with Oscar the Grouch instead.

An FDA advisory committee recommended that the agency authorize a booster dose of the Johnson & Johnson vaccine for everyone who received the vaccine.

For The Hill, we are Peter Sullivan ([email protected]), Nathaniel Weixel ([email protected]) and Justine Coleman ([email protected]). Write to us with tips and comments, and follow us on Twitter: @ PeterSullivan4, @NateWeixel and @ JustineColeman8.

Let’s get started.

FDA panel recommends booster injection of Johnson & Johnson vaccine

A Food and Drug Administration (FDA) advisory committee has voted to recommend authorization of a second dose of Johnson & Johnson’s COVID-19 vaccine.

The agency’s vaccine advisory committee voted unanimously, 19-0, to recommend authorization of a second dose as early as two months after the first injection for anyone aged 18 and over.

Unlike the recall authorizations for the Pfizer-BioNTech and Moderna vaccines, no restrictions were placed on the J&J recall. The panel said that the J&J vaccine, like other vaccines, requires two doses to be effective, although there has been heated debate over whether the J&J vaccine is in fact a two-dose vaccine, rather than one. single dose with a booster.

Representatives from Johnson & Johnson told the panel that a second dose given two months or six months after the first injection increased antibody levels, but that a single dose of the vaccine continued to provide protection.

The data relate to: Committee members expressed concern about the quality of the data presented by the company, as there were ultimately only 17 people included in an analysis, who were followed for six months. But at the same time, many have said they believe additional plans should be available.

If the vaccine is not adequate, then everyone should be boosted, ”said Eric Rubin, editor of the New England Journal of Medicine. “I don’t know why you are asking for an indication that would apply to millions of patients with a dataset comprising 17 patients,” he said.

Still, the FDA’s vote and subsequent action will likely add some clarity to the way forward for the 15 million people who have received a Johnson & Johnson vaccine.

And after: The recommendation will now be taken up by the FDA, which could take a decision in a few days. A panel from the Centers for Disease Control and Prevention is meeting on the issue next week.

Read more here.


This is our chance to expand access to healthcare. Join us on October 19 for Hill Day at Home – the biggest mental health and addiction promotion event of the year. Learn more.


The Justice Department announced plans to ask the Supreme Court to block Texas’ controversial new abortion law hours after a federal appeals court ruled the law could remain in effect while she was hearing the legal challenge from the Biden administration.

“The Department of Justice intends to ask the Supreme Court to overturn the Fifth Circuit’s suspension of the preliminary injunction against Bill 8 from the Texas Senate,” Anthony Coley, spokesperson, said Friday. of the department, in a press release sent by email.

A panel of three judges for the Fifth Circuit Court of Appeal ruled 2-1 late Thursday night in favor of keeping in force the law known as SB 8, quashing a trial judge’s injunction that blocked the ban on abortions after six weeks of pregnancy.

The ruling will once again present the Supreme Court with the question of whether to suspend SB 8, which has shut down many state abortion providers for fear of legal liability.

The High Court will hear another Mississippi abortion restriction case in December that directly challenges the landmark 1973 ruling in Roe v. Wade, who established a constitutional right to abortion.

The Texas law has been in effect since September 1, when the Supreme Court refused to prevent it from coming into effect in a 5-4 decision. Five of the Conservative High Court justices voted in favor of the law while Chief Justice John Roberts and the three members of the Liberal wing of the bench dissented.

Read more here.

United States to allow fully vaccinated international travelers to travel from November 8

The United States will lift border restrictions for fully vaccinated international travelers from November 8, according to the White House.

The policy will be effective for land borders and air travel.

Restrictions on international travelers have been renewed every month since the pandemic began in March 2020, even as other countries have opened their borders to fully vaccinated Americans.

The administration announced earlier this week that the land borders with Mexico and Canada would be open to fully vaccinated travelers in early November, although they did not set a specific date.

Unvaccinated travelers will still be banned from traveling to the United States by land for non-essential reasons until January. From the beginning of January, any foreign traveler crossing land borders must be fully vaccinated, whether coming for essential or non-essential reasons.

A similar policy for international air travel has been announced last month, when the White House said it would allow fully vaccinated travelers from 33 countries, including China, Brazil and most of Europe.

It is still unclear which vaccines will be eligible. The administration will leave it to the Centers for Disease Control and Prevention to determine that, although officials have indicated that people who have received a full dose of vaccines approved by the FDA or listed for emergency use by the Organization world health will meet the Criteria.

Read more here.

CDC data: unvaccinated people 11 times more likely to die from COVID-19 than fully vaccinated

Unvaccinated people have an 11 times higher risk of dying from COVID-19 than fully vaccinated people, according to new data published by the Centers for Disease Control and Prevention.

The data extends through August and comes from 16 health departments representing about 30% of the U.S. population, the CDC said.

Additionally, data shows unvaccinated people are six times more likely to test positive for COVID-19 than fully vaccinated people.

The data adds to a stack of evidence showing the reduced risks of the virus that vaccination brings. About 77 percent of the eligible population, people 12 and older, now have at least one shot of the vaccine, but the Biden administration has urged the remaining 23 percent to get the shot and turned to the requirements. vaccine as voluntary efforts as incentives. hit a ceiling.

Breakdown by vaccine type: The information comes from a new data page released by the CDC that also includes a breakdown based on the vaccine people received.

The risks are much higher for unvaccinated people than for those vaccinated, but the data shows somewhat higher levels of cases and deaths among people receiving the Johnson & Johnson vaccine, followed by Pfizer and then Moderna.

As of August 29, there were 665 cases per 100,000 people among the unvaccinated, compared to 150 among Johnson & Johnson recipients, 125 among Pfizer recipients, and 86 among Moderna recipients.

Read more here.


This is our chance to expand access to healthcare. Join us on October 19 for Hill Day at Home – the biggest mental health and addiction promotion event of the year. Learn more.


The Biden administration announced Thursday that it will invest $ 100 million to boost the health care sector by funding public programs aimed at attracting and retaining workers in underserved communities.

The Department of Health and Human Services (HHS) noted that the $ 100 million, which came from the US bailout, would go to support the National Health Service Corps’ State Loan Repayment Program (SLRP). .

What this implies: The program provides grants to states to help stimulate clinicians working in areas where healthcare shortages are known.

The HHS said it would disburse a maximum of 50 grants of up to $ 1 million each per year over four years, noting that this was a five-fold increase from previous SLRP funding.

Programs in states applying for federal grants will have until April 8, 2022 to submit applications, and the grants will be administered in September.

“Our healthcare workers have worked tirelessly to save lives throughout this pandemic and now it is our turn to invest in them,” the HHS secretary said. Xavier BecerraXavier Becerra FDA guidelines call for voluntary reduction of salt in food supply Half a loaf? Low-Income Seniors Receive Small Slice of Medicare Dental Benefits Biden Administration Approves Colorado Expansion of Transgender Health Coverage PLUS said in a statement.


  • Three lessons for the Covid-19 rapid test scale-up effort (New statistics)
  • Cities and police unions clash as vaccination mandates take effect (The Associated Press)
  • Here’s what happens next after an FDA panel recommended Moderna and J. & J. boosters. (The New York Times)


  • K-12 schools without a mask warrant in Michigan have seen 62% more coronavirus spread (Detroit Free Press)
  • W.Va. House passes the Vaccination Mandate Exemption Bill (WSAZ)
  • The Court of Appeal refuses to stop the mandate of the Mills vaccine (Bangor Daily News)

That’s all for today, thanks for reading. Check out The Hill’s healthcare page for the latest news and coverage. See you Monday.

Source link


Leave A Reply